Search Results
130 items found for "immune response"
- Ultrasensitive dose-response for asbestos cancer risk implied by new inflammation-mutation model
< GPCR News < GPCRs in Oncology and Immunology Ultrasensitive dose-response for asbestos cancer risk In contrast, a linear no-threshold (LNT) dose-response relationship is expected for damage that accumulates both, rendering ambiguous expectations concerning the nature of model-implied shape of the low-dose response somatic mutations) of the most efficient pathway to any type of cancer in any reparable tissue (Dose-Response
- Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure
Here, we use validated and certified immune assays presenting native receptors as binding targets. , cardiac function, volumes, and myocardial structural properties were assessed by cardiac magnetic resonance
- Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma
< GPCR News < GPCRs in Oncology and Immunology Prediction of survival and immunotherapy response by the
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
< GPCR News < GPCRs in Oncology and Immunology Spliceosome mutations are associated with clinical response The current study aimed to identify molecular predictors of response to ONV + DAC in R/R AML patients A 10-gene expression signature, predictive of response to ONV + DAC, was derived from the leading-edge The gene signature was not associated with response to DAC alone in an independent dataset. signature to the BeatAML cohort (n = 399), we identified a positive association between predicted ONV + DAC response
- Systems Pharmacodynamic Model of Combination Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways
Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways Published date October 31, 2023 Abstract performed, and a system pharmacodynamics model (SPD) was developed to capture pancreatic cancer cell responses Here we describe drug effects on pathways associated with cell cycle, DNA damage response (DDR), and
- Ep 142 with Dr Claudia Stäubert
Our ultimate goal is to understand their role in immune cell function and cancer cell metabolism. " Dr
- [Inhibitory effect of downregulating G protein-coupled receptor class C group 5 member A expression on lipopolysaccharide-induced inflammatory response in human gingival fibroblasts]
protein-coupled receptor class C group 5 member A expression on lipopolysaccharide-induced inflammatory response protein-coupled receptor class C group 5 member A (GPRC5A) on lipopolysaccharide (LPS)-induced inflammatory response
- Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes
to CXCL12 but induce different effector responses to regulate cell migration. protein-independent and scavenges CXCL12 to regulate extracellular chemokine levels and maintain CXCR4 responsiveness CXCR4 only responds to wild-type CXCL12 and is sensitive to mutation of the chemokine. By contrast, ACKR3 recruits GPCR kinases (GRKs) and β-arrestins and promiscuously responds to CXCL12, Multiple active-like ACKR3 conformations are populated in response to agonists, compared to the single
- Molecular characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq
Immunology Molecular characterization of breast cancer cell pools with normal or reduced ability to respond Keller , Nathalie Schuster , Stefan Aebi , Rolf Jaggi Tags Breast cancer cell pools , progesterone response
- Ep 60 with Dr. Josephine (Pina) Cardarelli
She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology with Biologics, and Antibody Drug Conjugates as well as experience in IND fillings, IB updates, and responding
- Using food perception and bioamine signaling networks to slow aging
The Leiser laboratory is focused on the molecular mechanisms of aging, with an emphasis on stress response Recent research in his laboratory focuses on how organisms perceive and respond to environmental stress
- Ep 98 with Dr. GPCR Team
As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and immuno-oncology past two decades studying structure/function relationships of GPCRs using live-cell bioluminescence resonance
- miR-19a may function as a biomarker of oral squamous cell carcinoma (OSCC) by regulating the signaling pathway of miR-19a/GRK6/GPCRs/PKC in a Chinese population
Chinese population Published date September 14, 2023 Abstract "The ability of animals to perceive and respond understanding various sensory modalities, the sense of hygrosensation, which involves the detection and response
- Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia
was to elucidate the genomic basis of drug resistance or sensitivity, identify signatures for drug response Statistical approaches and machine learning models were applied to identify signatures for drug response Using the mutation pattern for drug response prediction demonstrates high accuracy in predicting sensitivity study highlights the importance of considering the gene mutation patterns for the prediction of drug response
- From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction
The signaling pathways responsible for LPA/S1P-induced CCN1/2 typically involve activation of the small can potentially play roles in downstream signal transduction events required for LPA and S1P-induced responses activation of additional receptors and signal transduction pathways, contributing to the biphasic delayed responses typically seen in response to growth factors acting via GPCRs.
- Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production by inhibiting activation of pAKT pathways in primary T cells
Resting peripheral hM3Dq+PLCβ1 (hM3Dq/β1) T cells did not respond to clozapine, an hM3Dq agonist, unless This permitted large calcium and phosphorylated ERK responses to clozapine.
- Comparative analysis of the occupancy of Histone H3 Lysine 4 methylation in the cells treated with TGFβ and Interferonγ
Abstract "In this current study, we have compared our H3K4me3 Chip-Sequencing data in PC3 cells in response it would be of utmost importance to find out the regions undergoing histone modification changes in response Our study has compared the genes showing H3K4me3 occupancy in response to both TGFβ and IFNγ.
- Affiliate Policy | Dr. GPCR Ecosystem
This Affiliates Policy explains your rights and responsibilities when participating in the Dr. The affiliate is responsible for the entire amount of PayPal's processing fees when payments are made GPCR will be solely responsible for processing every order placed by a customer via affiliate links. GPCR will also be solely responsible for all customer service inquiries. Responsibility for Your Site You are solely responsible for your website, including its development,
- Terms and Conditions | Dr. GPCR Ecosystem
CUSTOMER INFORMATION: Customer is solely responsible for all data, information, and other materials that The customer is responsible to maintain the confidentiality of its login information and for all activities Accordingly, the Customer acknowledges that he is solely responsible for adequate security, protection The customer further acknowledges and agrees that Ecosystem.DrGPCR.com shall not be responsible or liable Ecosystem.DrGPCR.com shall not be responsible for the accuracy, availability, or reliability of any content
- Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1/Cdc42 axis
We also observed PTX-dependent TNT biogenesis in response to lysophosphatidic acid (LPA), indicative of a general response driven by Gi/o-coupled GPCRs. intricate signaling pathways governing the generation of specialized actin-rich elongated structures in response
- Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
Overall response and complete response upon salvage therapies were 79% and 39% for talquetamab, 64% and Duration of response, as well as median survival, was significantly improved with bispecific antibodies
- Content and Conduct Policy | Dr. GPCR Ecosystem
Responsibility for Your Content You alone are responsible for Your Content, and once published, it cannot In emergency situations, we may escalate imminent threats of serious harm to law enforcement.
- Illuminating Functional Selectivity and Allosterism at GPCRs.
program focuses on the molecular and cellular mechanisms regulating G protein-coupled receptor (GPCR) responses , a class of receptors involved in many, if not all, physiological responses, with the ultimate goal
- G Protein-coupled Receptor-mediated Membrane Targeting of PLCγ2 is Essential for Neutrophil Chemotaxis
In response to a chemoattractant stimulation, cells lacking PLCγ2 (plcg2kd) displayed altered dynamics of diacylglycerol (DAG) production and calcium response; increased Ras/PI3K/Akt activation; elevated
- Glucose and HODEs regulate Aspergillus ochraceus quorum sensing through the GprC-AcyA pathway
Here we show that the G protein-coupled receptor (GPCR) to cAMP pathway is responsible for transmitting that classified as sugar sensor, and intracellular adenylate cyclase (AcyA)-cAMP-PKA pathway that in response
- Ep 57 with Dr. Peter Robert Banks
His responsibilities include the management of the company’s applications team and providing scientific
- Ep 134 with Dr. Neil Grimsey
To further define the role of atypical p38 signaling responses we are studying how atypical p38 controls
- Privacy Policy | Dr. GPCR Ecosystem
Third-party cookie usage is subject to their privacy policies, and Ecosystem.DrGPCR.com assumes no responsibility when: - We have your express consent to share the information for a specified purpose; - We need to respond